Nuveen Fund Advisors’s Braskem BAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-10,016
Closed -$263K 255
2017
Q4
$263K Sell
10,016
-1,499
-13% -$42.8K 0.08% 251
2017
Q3
$308K Sell
11,515
-15,984
-58% -$392K 0.06% 280
2017
Q2
$564K Buy
27,499
+595
+2% +$12.3K 0.09% 245
2017
Q1
$561K Buy
26,904
+1,251
+5% +$26.3K 0.07% 271
2016
Q4
$544K Buy
25,653
+1,363
+6% +$24.1K 0.08% 267
2016
Q3
$374K Buy
24,290
+9,706
+67% +$127K 0.05% 338
2016
Q2
$173K Buy
+14,584
New +$182K 0.03% 425

Other funds holding BAK

Nuveen Fund Advisors's BAK Position: Q1 2018 in Review

Nuveen Fund Advisors sold out of Braskem (BAK) in Q1 2018, closing a stake of 10,016 shares — an estimated $263K sold.

Nuveen Fund Advisors first reported a position in BAK in Q2 2016 and held it in 7 quarters. The position peaked at $564K in Q2 2017. 104 funds tracked by Wall St. Rank hold BAK as of Q1 2018.

  • Nuveen Fund Advisors reported no remaining Braskem position as of Q1 2018 after selling out during the quarter.
  • Nuveen Fund Advisors sold 10,016 Braskem shares in Q1 2018, an estimated $263K.
  • Nuveen Fund Advisors first reported a position in Braskem in Q2 2016 and held it in 7 quarters.
  • Nuveen Fund Advisors's Braskem position peaked at $564K in Q2 2017.
  • 104 funds tracked by Wall St. Rank held Braskem as of Q1 2018.

Based on Nuveen Fund Advisors's 13F filing for Q1 2018, filed 14 May 2018.